Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Gökhan Yoca"'
Autor:
Berna B Kıvırcık Akdede, Alp Üçok, Kristel R. van Eijk, Evelien Van Assche, Edwin Beld, Dan Cohen, Yasemin Görgülü, Jelena Medic, Vesile Altınyazar, Erwin Bekema, Cynthia Okhuijsen-Pfeifer, Jurjen J. Luykx, Gökhan Yoca, Yavuz Ayhan, Jan P.A.M. Bogers, Memduha Aydin, Mustafa Çelik, A Elif Anıl Yağcıoğlu, Hasret Ozan, Fatma Özlem Orhan, Ayşen Esen Danacı, Bilge Çetin İlhan, Semra Ulusoy, Hatice Özdemir, İsmet Kaygısız, Haldun Soygür, Hanneke van Beek, Annemieke A M de Jonge, Köksal Alptekin, Ahmet Muderrisoglu, Lindy J G B Kool, Melih O. Babaoglu, Bochao D. Lin, Selene R. T. Veerman
Publikováno v:
Schizophrenia Bulletin Open. 1
Clozapine (CLZ) is considered the most effective antipsychotic, but its use is associated with neutropenia (CIN) and agranulocytosis (CIA). Although the exact etiology of these hazardous side effects is unknown, 4 genetic polymorphisms have been impl
Publikováno v:
Turk psikiyatri dergisi = Turkish journal of psychiatry. 29(3)
Current drug treatments for schizophrenia are only partially effective and combination/augmentation strategies are commonly used. Nitric Oxide (NO) may play a role in the pathophysiology of schizophrenia. L-arginine is the precursor of NO. In this st
Autor:
Emine Akal Yıldız, Gökhan Yoca, I. Türkoğlu, Seyit M Mercanlıgil, A. Elif Anıl Yağcıoğlu, M. Kâzım Yazıcı, Nurhayat Eni, Sevilay Karahan
Publikováno v:
European archives of psychiatry and clinical neuroscience. 270(5)
The prevalence of metabolic syndrome (MetS) in schizophrenia patients is increasing worldwide. The aim of the current study was to examine the progress of MetS in a schizophrenia cohort we had previously investigated and determine the role of various
Autor:
R. Özgür Karaca, Melih O. Babaoglu, Ahmet Muderrisoglu, Nurhayat Eni, Gökhan Yoca, Yavuz Ayhan, A. Elif Anil Yağcioğlu, Mustafa Tugrul Goktas, Atilla Bozkurt, Lokman Cevik, M. Kâzım Yazıcı
Publikováno v:
Journal of Clinical Psychopharmacology. 36:257-261
Clozapine use is associated with leukopenia and more rarely agranulocytosis, which may be lethal. The drug and its metabolites are proposed to interact with the multidrug resistance transporter (ABCB1/MDR1) gene product, P-glycoprotein (P-gp). Among
Objective Current drug treatments for schizophrenia are only partially effective and combination/augmentation strategies are commonly used. Nitric Oxide (NO) may play a role in the pathophysiology of schizophrenia. L-arginine is the precursor of NO.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d65f404d6904f1e1c22971caf80b9d08
http://hdl.handle.net/11655/14242
http://hdl.handle.net/11655/14242
Publikováno v:
Clinical Nutrition. 36:S45
Publikováno v:
Clinical Nutrition. 36:S165
Publikováno v:
Clinical Nutrition. 36:S147
Autor:
Lokman Cevik, Yavuz Ayhan, R. Özgür Karaca, A. Elif Anıl Yağcıoğlu, M Kazım Yazıcı, Atilla Bozkurt, Melih O. Babaoglu, Nurhayat Eni, Gökhan Yoca
Publikováno v:
Schizophrenia Research. 153:S189-S190